Related Experiment Video
Updated: Sep 30, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
Narrowband UVB phototherapy for early-stage mycosis fungoides
Raechele Cochran Gathers1, Lubomira Scherschun, Farah Malick
1Department of Dermatology, Henry Ford Health System, Detroit, MI 48202-2689, USA.
Background:
Narrowband UVB (NB-UVB) phototherapy has been shown to be effective for the treatment of various dermatoses.
Objective:
We evaluated the effect of NB-UVB in the treatment of early stage mycosis fungoides (MF).
Methods:
The response of 24 patients (12 stage IA, 12 stage IB) with patch stage MF to thrice weekly NB-UVB was assessed. Twelve patients had skin phototypes I-III, and 12 had types IV-VI. Seven patients had hypopigmented MF. Mean follow-up period was 29.0 weeks.
Results:
Thirteen patients (54.2%) had a complete response (CR), 7 (29.2%) had partial response (PR), and 4 (16.7%) had no response. Specimens from a repeat biopsy in 10 patients with CR showed histologic clearing in 9 of them. Upon discontinuation of treatment, 4 patients with CR relapsed, with a mean time to relapse of 12.5 weeks.
Conclusion:
NB-UVB is a viable, comparably safe, and easily administered alternative in the management of early stage MF.
Related Concept Videos
Acne Infection
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
